DK169032B1 - 5,6-dihydro-2-(substitueret phenyl)-1,2,4-triazin-3,5(2H, 4H)-dioner, fremgangsmåde til fremstilling deraf og præparater indeholdende disse forbindelser - Google Patents

5,6-dihydro-2-(substitueret phenyl)-1,2,4-triazin-3,5(2H, 4H)-dioner, fremgangsmåde til fremstilling deraf og præparater indeholdende disse forbindelser Download PDF

Info

Publication number
DK169032B1
DK169032B1 DK048187A DK48187A DK169032B1 DK 169032 B1 DK169032 B1 DK 169032B1 DK 048187 A DK048187 A DK 048187A DK 48187 A DK48187 A DK 48187A DK 169032 B1 DK169032 B1 DK 169032B1
Authority
DK
Denmark
Prior art keywords
formula
parts
hydrogen
triazine
compounds
Prior art date
Application number
DK048187A
Other languages
Danish (da)
English (en)
Other versions
DK48187A (da
DK48187D0 (da
Inventor
Gustaaf Maria Boeckx
Alfons Herman Marg Raeymaekers
Victor Sipido
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK48187D0 publication Critical patent/DK48187D0/da
Publication of DK48187A publication Critical patent/DK48187A/da
Application granted granted Critical
Publication of DK169032B1 publication Critical patent/DK169032B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK048187A 1986-01-30 1987-01-29 5,6-dihydro-2-(substitueret phenyl)-1,2,4-triazin-3,5(2H, 4H)-dioner, fremgangsmåde til fremstilling deraf og præparater indeholdende disse forbindelser DK169032B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8602342 1986-01-30
GB868602342A GB8602342D0 (en) 1986-01-30 1986-01-30 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones

Publications (3)

Publication Number Publication Date
DK48187D0 DK48187D0 (da) 1987-01-29
DK48187A DK48187A (da) 1987-07-31
DK169032B1 true DK169032B1 (da) 1994-08-01

Family

ID=10592258

Family Applications (2)

Application Number Title Priority Date Filing Date
DK048187A DK169032B1 (da) 1986-01-30 1987-01-29 5,6-dihydro-2-(substitueret phenyl)-1,2,4-triazin-3,5(2H, 4H)-dioner, fremgangsmåde til fremstilling deraf og præparater indeholdende disse forbindelser
DK93651A DK65193D0 (da) 1986-01-30 1993-06-04 4,5-dihydro-2-(substitueret phenyl)-1,2,4-triazin-3,5(3h)-dionforbindelser, fremgangsmaade til fremstilling deraf samt praeparater indeholdende disse forbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK93651A DK65193D0 (da) 1986-01-30 1993-06-04 4,5-dihydro-2-(substitueret phenyl)-1,2,4-triazin-3,5(3h)-dionforbindelser, fremgangsmaade til fremstilling deraf samt praeparater indeholdende disse forbindelser

Country Status (21)

Country Link
US (3) US4767760A (es)
EP (1) EP0232932B1 (es)
JP (2) JPH0813806B2 (es)
CN (1) CN1017049B (es)
AT (1) ATE59644T1 (es)
AU (1) AU586731B2 (es)
CA (2) CA1288772C (es)
DE (1) DE3766839D1 (es)
DK (2) DK169032B1 (es)
ES (1) ES2031876T3 (es)
FI (1) FI94634C (es)
GB (1) GB8602342D0 (es)
GR (1) GR3001392T3 (es)
IE (1) IE59510B1 (es)
IL (1) IL81421A (es)
NO (1) NO172690C (es)
NZ (1) NZ218973A (es)
PT (1) PT84218B (es)
RU (1) RU2017736C1 (es)
SU (1) SU1595339A3 (es)
ZA (1) ZA87672B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097779A (en) * 1976-04-05 1978-06-27 Gte Sylvania Incorporated Fluorescent lamp containing a cathode heater circuit disconnect device
US4156831A (en) * 1978-05-24 1979-05-29 Gte Sylvania Incorporated Fluorescent lamp having heater circuit disconnect device
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
DE3826058A1 (de) * 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
US5070091A (en) * 1989-01-09 1991-12-03 Bayer Aktiengesellschaft Substituted 1,2,4-triazinediones useful against protozoa in insects
EP0377903A3 (de) * 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
CN1044905A (zh) * 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
CA2012004A1 (en) * 1989-03-15 1990-09-15 Frank Ellis Chemical compounds
EP0476439A1 (de) * 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
DE4120138A1 (de) * 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
US5994355A (en) * 1993-10-15 1999-11-30 Takeda Chemical Industries, Ltd. 1, 2, 4-Triazin-3-one derivatives, production and use thereof
DE69615601T2 (de) * 1995-04-14 2002-07-11 Takeda Schering Plough Animal Verfahren zur Herstellung von Triazinderivate
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
KR19980019182A (ko) * 1996-08-30 1998-06-05 다께다 구니오 1,2,4-트리아진-3,5-디온 유도체, 그의 생성법 및 그의 용도(1,2,4-triazine-3,5-dione derivatives, their production a nd use thereof)
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
BR9808114A (pt) * 1997-03-31 2000-03-08 David Granstrom Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos
US5830893A (en) * 1997-04-23 1998-11-03 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones
CN1261881A (zh) * 1997-07-10 2000-08-02 詹森药业有限公司 作为il-5-抑制剂的6-氮杂尿嘧啶衍生物
ATE364597T1 (de) * 1997-07-10 2007-07-15 Janssen Pharmaceutica Nv Il-5 hemmende 6-azauracilderivate
US6867207B2 (en) 1997-07-10 2005-03-15 Janssen Pharmaceutica N.V. IL-5 inhibiting 6-azauracil derivatives
TW450964B (en) 1997-08-29 2001-08-21 Takeda Schering Plough Animal Triazine derivatives, their production and use
WO2000006172A1 (en) * 1998-07-27 2000-02-10 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones
EP0987265A1 (en) 1998-09-18 2000-03-22 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
WO2000019964A2 (en) * 1998-10-08 2000-04-13 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
BR9916366A (pt) * 1998-12-18 2001-09-18 Janssen Pharmaceutica Nv Derivados de 6-azauracila, inibidores de il-5
CN1188410C (zh) 1999-08-06 2005-02-09 詹森药业有限公司 非类固醇类的il-5抑制剂,其制备的方法以及包含该抑制剂的医药组合物
PA8591801A1 (es) * 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
GB0622472D0 (en) * 2006-11-10 2006-12-20 Addex Pharmaceuticals Sa Novel heterocyclic derivatives
CN107746390B (zh) * 2017-11-21 2021-03-16 连云港市亚晖医药化工有限公司 抗球虫药地克珠利的制备方法
CN113999139A (zh) * 2021-12-03 2022-02-01 杭州臻峰科技有限公司 制备2,6-二氯-α-(4-氯代苯基) -4-硝基苯乙腈的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3905971A (en) * 1971-03-29 1975-09-16 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
US3912723A (en) * 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
GB1448696A (en) * 1973-05-29 1976-09-08 Pfizer 2-phqnyl-astriazine-3,4-2h,4h-diones
DE3408924A1 (de) * 1984-03-12 1985-09-26 Hoechst Ag, 6230 Frankfurt Substituierte 2-phenyl-hexahydro-1,2,4-triazin-3,5-dione, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
US4631278A (en) * 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
CA1244024A (en) * 1984-08-01 1988-11-01 Gustaaf M. Boeckx .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones

Also Published As

Publication number Publication date
EP0232932A1 (en) 1987-08-19
JPH0813806B2 (ja) 1996-02-14
DK65193A (da) 1993-06-04
AU6813487A (en) 1987-08-06
GR3001392T3 (en) 1992-09-11
DK48187A (da) 1987-07-31
JPH07285949A (ja) 1995-10-31
EP0232932B1 (en) 1991-01-02
JPS62190174A (ja) 1987-08-20
CA1288772C (en) 1991-09-10
FI94634C (fi) 1995-10-10
IE59510B1 (en) 1994-03-09
US4767760A (en) 1988-08-30
DE3766839D1 (de) 1991-02-07
ES2031876T3 (es) 1993-01-01
FI870421A0 (fi) 1987-01-30
NO870378L (no) 1987-07-31
FI870421A (fi) 1987-07-31
IL81421A (en) 1991-11-21
SU1595339A3 (ru) 1990-09-23
PT84218B (pt) 1989-07-31
DK48187D0 (da) 1987-01-29
GB8602342D0 (en) 1986-03-05
NO172690C (no) 1993-08-25
IE870231L (en) 1987-07-30
NO870378D0 (no) 1987-01-29
ZA87672B (en) 1988-09-28
US4912106A (en) 1990-03-27
RU2017736C1 (ru) 1994-08-15
ATE59644T1 (de) 1991-01-15
AU586731B2 (en) 1989-07-20
IL81421A0 (en) 1987-08-31
CN87100531A (zh) 1987-09-02
JP2622510B2 (ja) 1997-06-18
US4952570A (en) 1990-08-28
FI94634B (fi) 1995-06-30
CA1302411C (en) 1992-06-02
NO172690B (no) 1993-05-18
NZ218973A (en) 1988-10-28
PT84218A (en) 1987-02-01
CN1017049B (zh) 1992-06-17
DK65193D0 (da) 1993-06-04

Similar Documents

Publication Publication Date Title
DK169032B1 (da) 5,6-dihydro-2-(substitueret phenyl)-1,2,4-triazin-3,5(2H, 4H)-dioner, fremgangsmåde til fremstilling deraf og præparater indeholdende disse forbindelser
DK166414B1 (da) Alfa-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3h)-yl)-benzenacetonitriler, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende forbindelserne
CA2599860C (en) 1, 2, 4-triazole derivatives and their use as oxytocin antagonists
MXPA02009783A (es) Derivados de n-alquil-adamantil-triazinil-benzamida.
NO316273B1 (no) Substituerte 6,6-hetero-bicykliske derivater og farmasöytiske preparater inneholdende dem
US4631278A (en) Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
MXPA06014025A (es) Derivados de triazol sustituidos como antagonistas de oxitocina.
MXPA06015273A (es) Procedimiento para preparar derivados de 5-[4-(2-hidroxi -etil)-3, 5-dioxo-4, 5-dihidro-3h-[1, 2, 4]-triazin -2-il]-benzamida con actividad inhibidora de p2x7 mediante reaccion del derivado no sustituido en posicion 4 de la triazina con un oxirano en
SK13752002A3 (sk) Difenyléterové zlúčeniny užitočné pri liečení
FI94757B (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-/1-tiatsolidinyylibutyyli-4-piperatsinyyli/-1H-indatsolien valmistamiseksi
NO175056B (no) Analogifremgangsmåte for fremstilling av 2-(substituert fenyl)-1,2,4-triazin-3,5-(2H,4H)-dioner
US4778887A (en) α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitriles
US20070105870A1 (en) Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-uptake inhibitors
HUT54125A (en) Process for producing triazine derivatives and pharmaceutical compositions comprising same
EP1917257A1 (en) Substituted triazole derivatives as oxytocin antagonists
EP0000382B1 (en) Pyrimido (4,5-c)pyridazines, compositions containing them and processes for their preparation

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed